Clinical assessment of antiarrhythmic agents for paroxysmal atrial fibrillation guided by modification of electrophysiologic arrhythmogenicity

Journal of Cardiovascular Electrophysiology

Volumn 15, Issue 11, 2004, Pages 1250-1257

  Sasano, Tetsuo ^a   Okishige, Kaoru ^a   Azegami, Kouji ^a   Isobe, Mitsuaki ^b  

^a YOKOHAMA CITY MINATO RED CROSS HOSPITAL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Antiarrhythmic agent; Electrophysiology; Fibrillation; Remodeling

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTIARRHYTHMIC AGENT; APRINDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CIBENZOLINE; DISOPYRAMIDE;

ADULT; AGED; ARTICLE; DRUG EFFICACY; ELECTROPHYSIOLOGY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFRACTORY PERIOD;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; ELECTROPHYSIOLOGY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 10044257566     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2004.03706.x     Document Type: Article

References (26)

1. Godtfredsen J: Atrial fibrillation: Course and prognosis. A follow up study of 1212 cases. In Kulvertus HE, Olsson SB, Schlepper M, eds: Atrial Fibrillation. Sweden: Lindgren and Soner. 1982:134-138.
2. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA: Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
3. Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, Morady F: Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996;94:1600-1606.
4. Yu WC, Chen SA, Lee SH, Tai CT, Feng AN, Kuo BI, Ding YA, Chang MS: V Tachycardia-induced change of atrial refractory period in humans: Rate dependency and effects of antiarrhythmic drugs. Circulation 1998;97:2331-2337.
5. Garratt CJ, Duytschaever M, Killian M, Dorland R, Mast F, Allessie MA: Repetitive electrical remodeling by paroxysms of atrial fibrillation in the goat: No cumulative effect on inducibility or stability of atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:1101-1108.
6. Kubara I, Ikeda H, Hiraki T, Yoshida T, Ohga M, Imaizumi T: Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: Its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 1999;10:670-679.
7. Jose AD, Taylor RR: Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest 1969;48:2019-2031.
8. Wyndham CR, Amat-y-Leon F, Wu D, Denes P, Dhingra R, Simpson R, Rosen KM: Effects of cycle length on atrial vulnerability. Circulation 1977;55:260-267.
9. Zimmermann M, Adamec R, Metzger J: Atrial vulnerability in patients with paroxysmal "lone" atrial fibrillation. Pacing Clin Electrophysiol 1998;21:1949-1958.
10. Kumagai K, Akimitsu S, Kawahira K, Kawanami F, Yamanouchi Y, Hiroki T, Arakawa K: Electrophysiological properties in chronic lone atrial fibrillation. Circulation 1991;84:1662-1668.
11. Hashiba K, Tanigawa M, Fukatani M, Shimizu A, Konoe A, Kadena M, Mori M: Electrophysiologic properties of atrial muscle in paroxysmal atrial fibrillation. Am J Cardiol 1989;64:20J-23J.
12. Leier CV, Meacham JA, Schaal SF: Prolonged atrial conduction: A major predisposing factor for the development of atrial flutter. Circulation 1978;57:213-216.
13. Morillo CA, Klein GJ, Jones DL, Guiraudon CM: Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-1595.
14. Goette A, Honeycutt C, Langberg JJ: Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-2974.
15. Daoud EG, Knight BP, Weiss R, Bahu M, Paladino W, Goyal R, Man KC, Strickberger SA, Morady F: Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 1997;96:1542-1550.
16. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997;80:772-781.
17. Masse C, Cazes M, Sassine A: Effects of cibenzoline, a novel antiarrhythmic drug, on action potential and transmembrane currents in frog atrial muscle. Arch Int Pharmacodyn Ther 1984;269:219-235.
18. Shibasaki T, Tojima S, Ito H, Hirakawa S: Effects of anti-arrhythmic drugs on action potential repolarization of guinea-pig atrial myocytes (in Japanese). Shinzou 1991;23:327-331.
19. Tieleman RG, De Langen C, Van Gelder IC, de Kam PJ, Grandjean J, Bel KJ, Wijffels MC, Allessie MA, Crijns HJ: Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;95:1945-1953.
20. 2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 1999;100:2191-2197.
21. Fuchs T, Podrid PJ: Pharmacologic therapy for reversion of atrial fibrillation and maintenance of sinus rhythm. In Falk RH, Podrid PJ, eds: Atrial Fibrillation: Mechanisms and Management. New York: Raven Press, 1992:253-254.
22. Wilber DJ, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN: Out-of hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988;318;19-24.
23. Allessie MA, Wijffels MC, Dorland R: Mechanisms of pharmacologic cardioversion of atrial fibrillation by class 1 drugs. J Cardiovasc Electrophysiol 1998;9:S69-S77.
24. Brachmann J, Karolyi L, Kubler W: Atrial dispersion of refractoriness. J Cardiovasc Electrophysiol 1998;9:S35-S39.
25. Attuel P, Childers R, Cauchemez B, Poveda J, Mugica J, Coumel P: Failure in the rate adaptation of the atrial refractory period: Its relationship to vulnerability. Int J Cardiol 1982;2:179-197.
26. van der Velden HMW, van der Zee L, Wijffels MC, van Leuven C, Dorland R, Vos MA, Jongsma HJ, Allessie MA: Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization. J Cardiovasc Electrophysiol 2000;11:1262-1269.